
June 5 (Reuters) - LivaNova PLC LIVN.O:
LIVANOVA ANNOUNCES CORE-VNS 24-MONTH DATA SHOW ADJUNCTIVE VNS THERAPY IS ASSOCIATED WITH SUBSTANTIAL REDUCTIONS IN GENERALIZED TONIC-CLONIC SEIZURES IN PEOPLE WITH DRUG-RESISTANT EPILEPSY
LIVANOVA PLC - 77% MEDIAN SEIZURE REDUCTION, 43% SEIZURE FREEDOM AT 24 MONTHS
LIVANOVA PLC - 52% MEDIAN SEIZURE REDUCTION AT THREE MONTHS